Skip to main content
Log in

Case seminar: a young female with acute hyponatremia and a sellar mass

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

In familial cases of combined pituitary hormone deficiency the most common mutations are that of Prophet of Pit 1 (PROP1) gene. PROP1 mutations are associated with deficiencies of growth hormone, thyrotropin, prolactin, and gonadotropins (follicle-stimulating hormone and luteinizing hormone), with evolving adrenocorticotropin (ACTH) deficiency in some cases. On imaging in most patients the pituitary gland is hypoplastic, but occasionally transient pituitary enlargement is found. We report a 22-year-old female initially diagnosed at age 12 with familial hypopituitarism due to PROP1 mutation, who presented with coma and respiratory arrest (acute hyponatremia). She was urgently treated in Intensive Care Unit of Emergency Center with hypertonic saline and stress doses of hydrocortisone, which resulted in the fast increase of plasma osmolality resulting in the osmotic demyelination syndrome. Simultaneously and incidentally on computed tomography scan a large sellar and suprasellar mass were reported as possible Rathke’s cleft cyst or craniopharyngioma. Once the patient was stable, ACTH deficiency was documented. She remained replaced with hydrocortisone and subsequently underwent transphenoidal surgery. The removed sellar content revealed no pituitary adenoma or pituitary cells, but only an eosinophilic, colloid-like mass, and necrotic acellular debris. Her sister with hypopituitarism had an empty sella. Genetic testing in both sisters revealed the same homozygous c.150delA mutation in PROP1 gene. Here we report two sisters with the same PROP1 mutation who presented in adulthood with different pituitary morphology, one of them with a large sellar and suprasellar mass, in which transphenoidal surgery provided an extremely rare opportunity for a histopathological analysis of the sellar content. Due to the lack of endocrine care during the transition period hypocortisolism which evolved, a consequence of PROP1 mutation, was not recognized. Empirical use of hydrocortisone in the Intensive Care in our patient with life-threatening acute hyponatremia was appropriate but because glucocorticoid therapy on its own corrects hyponatremia even after stopping hypertonic saline infusion, the risk for over-correction of hyponatremia in ACTH deficiency is high.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. J.S. Dasen, J.P. Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju, J. Tollkuhn, S.H. Baek, D.W. Rose, M.G. Rosenfeld, Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev. 15, 3193–3207 (2001)

    Article  PubMed  CAS  Google Scholar 

  2. M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, I. Gukovsky, C. Carrière, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996)

    Article  PubMed  CAS  Google Scholar 

  3. P.J. Gage, M.L. Brinkmeier, L.M. Scarlett, L.T. Knapp, S.A. Camper, K.A.L. Mahon, The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol. Endocrinol. 10, 1570–1581 (1996)

    Article  PubMed  CAS  Google Scholar 

  4. L.E. Cohen, Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 12, 99–106 (2000)

    Article  PubMed  CAS  Google Scholar 

  5. M.T. Dattani, I.C. Robinson, The molecular basis for developmental disorders of the pituitary gland in man. Clin. Genet. 57, 337–346 (2000)

    Article  PubMed  CAS  Google Scholar 

  6. S. Mody, M. Brown, J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract. Res. Clin. Endocrinol. Metab. 16, 421–431 (2002)

    Article  PubMed  CAS  Google Scholar 

  7. M.T. Dattani, Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin. Endocrinol. 63, 121–130 (2005)

    Article  CAS  Google Scholar 

  8. W. Wu, J.P. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O′Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips 3rd, M.G. Rosenfeld, Mutation in PROP1 cause familial combined pituitary hormone deficiency. Nat. Genet. 18, 147–149 (1998)

    Article  PubMed  CAS  Google Scholar 

  9. A.L. Rosenbloom, A.S. Almonte, M.R. Brown, D.A. Fisher, L. Baumbach, J.S. Parks, Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50–57 (1999)

    Article  PubMed  CAS  Google Scholar 

  10. A. Arroyo, F. Pernasetti, V.V. Vasilyev, P. Amato, S.S.C. Yen, P.L. Mellon, A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin. Endocrinol. 57, 283–291 (2002)

    Article  Google Scholar 

  11. M. Doknic, S. Pekic, M. Djurovic, V. Zivkovic, V. Popovic, Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr. Endocrinol. Rev. 1, 32–33 (2004)

    Google Scholar 

  12. M.T. Dattani, GH deficiency might be associated with normal height in PROP1 deficiency. Clin. Endocrinol. 57, 157–158 (2002)

    Article  Google Scholar 

  13. T.C. Vieira, M.R. da Silva, J. Abucham, The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 30, 365–369 (2006)

    Article  PubMed  CAS  Google Scholar 

  14. R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, A. Barlier, Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006)

    Article  PubMed  CAS  Google Scholar 

  15. R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, T. Brue, A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J. Clin. Endocrinol. Metab. 89, 5779–5786 (2004)

    Article  PubMed  CAS  Google Scholar 

  16. J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps, M.P. Wajnrajch, Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999)

    Article  PubMed  CAS  Google Scholar 

  17. J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hidnmarsh, W. Wu, P.E. Mullis, “Hot spot” in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 84, 1645–1650 (1999)

    Article  PubMed  CAS  Google Scholar 

  18. S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J.L. Chaussain, R. Brauner, I. Pellegrini-Bouiloler, P. Jaquet, A. Enjalbert, T. Brue, PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab. 86, 4529–4535 (2001)

    Article  PubMed  CAS  Google Scholar 

  19. R. Reynaud, A. Barlier, S. Vallette-Kasic, A. Saveanu, M.P. Guillet, G. Simonin, A. Enjalbert, P. Valensi, T. Brue, An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J. Clin. Endocrinol. Metab. 90, 4880–4887 (2005)

    Article  PubMed  CAS  Google Scholar 

  20. B.B. Mendonca, M.G.F. Osorio, A.C. Latronico, V. Estefan, L. Su Sih Lo, I. Arnhold, Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 942–945 (1999)

    Article  PubMed  CAS  Google Scholar 

  21. G. Agarwal, V. Bhatia, S. Cook, P.Q. Thomas, Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J. Clin. Endocrinol. Metab. 85, 4556–4561 (2000)

    Article  PubMed  CAS  Google Scholar 

  22. F. Pernasetti, S.P.A. Toledo, V.V. Vasilyev, C.Y. Hayashida, J.D. Cogan, C. Ferrari, D.M. Lourenco, P.L. Mellon, Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the Prophet of Pit-1 gene. J. Clin. Endocrinol. Metab. 85, 390–397 (2000)

    Article  PubMed  CAS  Google Scholar 

  23. A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J.F.W. Weigel, A. Keller, W. Hirsch, W. Kiess, W.F. Blum, R.W. Pfaffle, PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab. 89, 5256–5265 (2004)

    Article  PubMed  Google Scholar 

  24. S. Nakamura, A. Ohtsuru, N. Takamura, G. Kitange, Y. Toukunaga, A. Yasunaga, S. Shibata, S. Yamashita, Prop-1 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 84, 2581–2584 (1999)

    Article  PubMed  CAS  Google Scholar 

  25. K. Thapar, K. Kovacs, B.W. Scheitauer, M.O. Lloyd (eds.), Diagnosis and management of pituitary tumors (Humana press, Totowa, 2001)

    Google Scholar 

  26. R. Carpinteri, I. Patelli, F.F. Casanueva, A. Giustina, Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract. Res. Clin. Endocrinol. Metab. 23, 639–650 (2009)

    Article  PubMed  CAS  Google Scholar 

  27. P. Fofanova, N. Takamura, E. Kinoshita, A. Vorontson, V. Vladimirova, I. Dedov, V. Peterkova, S. Yamashita, MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am. J. Roentgenol. 174, 555–559 (2000)

    CAS  Google Scholar 

  28. A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, C. Dacou-Voutetakis, Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J. Clin. Endocrinol. Metab. 89, 2200–2206 (2004)

    Article  PubMed  CAS  Google Scholar 

  29. M.G. Abrao, M.V. Leite, L.R. Carvalho, A.E.C. Billerbeck, M.Y. Nishi, A.S. Barbosa, R.M. Martin, I.J.P. Arnhold, B.B. Mendonca, Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. 65, 294–300 (2006)

    Article  CAS  Google Scholar 

  30. J.S. Parks, A. Tenore, A.M. Bongiovanni, R.T. Kirkland, Familial hypopituitarism with large sella turcica. N. Engl. J. Med. 298, 698–702 (1978)

    Article  PubMed  CAS  Google Scholar 

  31. F.G. Riepe, C.J. Partsch, O. Blankenstein, H. Monig, R.W. Pfaffle, W.G. Sippell, Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J. Clin. Endocrinol. Metab. 86, 4353–4357 (2001)

    Article  PubMed  CAS  Google Scholar 

  32. C. Teinturier, S. Vallete, C. Adamsbaum, M. Bendaoud, T. Brue, P.F. Bougneres, Pseudotumor of the pituitary due to PROP-1 deletion. J. Clin. Endocrinol. Metab. 15, 95–101 (2002)

    CAS  Google Scholar 

  33. A. Zygmunt-Gorska, J. Starzyk, D. Adamek, E. Radwanska, P. Sucharski, I. Herman-Sucharska, J.J. Pietrzyk, Pituitary enlargement in patient with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. J. Pediatr. Endocrinol. Metab. 22, 653–660 (2009)

    Article  PubMed  CAS  Google Scholar 

  34. R.D. Ward, L.T. Raetzman, H. Suh, B.M. Stone, I.O. Nasonkin, S.A. Camper, Role of PROP1 in pituitary gland growth. Endocrinol. 19, 698–710 (2005)

    CAS  Google Scholar 

  35. J.A. Loh, J.G. Verbalis, Disorders of water and salt metabolism associated with pituitary disease. Endocrinol. Metab. Clin. North Am. 37, 213–234 (2008)

    Article  PubMed  CAS  Google Scholar 

  36. J.G. Verbalis, S.R. Goldsmith, A. Greenberg, R.W. Schrier, R.H. Sterns, Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120(suppl 1), S1–S21 (2007)

    Article  PubMed  CAS  Google Scholar 

  37. W.B. Schwartz, W. Bennett, S. Curelop, F.C. Bartter, A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med. 23, 529–542 (1957)

    Article  PubMed  CAS  Google Scholar 

  38. I.N. Mandell, R.A. DeFronzo, G.L. Robertson, F.N.J. Forrest, Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 17, 186–195 (1950)

    Article  Google Scholar 

  39. W. Oelkers, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med. 321, 492–496 (1989)

    Article  PubMed  CAS  Google Scholar 

  40. R.H. Sterns, J.E. Riggs, S.S. Schochet Jr., Osmotic demyelination syndrome following correction of hyponatremia. N. Engl. J. Med. 314, 1535–1542 (1986)

    Article  PubMed  CAS  Google Scholar 

  41. J.G. Verbalis, Hyponatremia. Endocrinologic causes and consequences of therapy. Trends Endocrinol. Metab. 3, 1–7 (1992)

    Article  PubMed  CAS  Google Scholar 

  42. A. Perianayagam, R.H. Sterns, S.M. Silver, M. Grieff, R. Mayo, J. Hix, R. Kouides, DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3, 331–336 (2008)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Dr. Joseph G. Verbalis, Georgetown University Medical Center, Washington, DC for his substantial and important contribution in discussing the clinical course and management of hyponatremia in our patient. Genetic analysis of the PROP1 gene in both sisters and mother was performed in the Laboratoire de Biologie Moleculaire, Hopital de la Conception, Marseille, France (Prof. Alain Enjalbert). This investigation was supported by a grant from the Ministry of Science of Republic of Serbia (Project 175033) and a grant from the French National Research Agency (ANR-08-GENO-026-01).

Conflict of interest

The authors have nothing to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vera Popovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pekic, S., Doknic, M., Miljic, D. et al. Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 40, 325–331 (2011). https://doi.org/10.1007/s12020-011-9516-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-011-9516-8

Keywords

Navigation